Mehta, Nehal N. https://orcid.org/0000-0003-4939-5130
deGoma, Emil https://orcid.org/0000-0001-9439-6912
Shapiro, Michael D. https://orcid.org/0000-0002-9071-3287
Article History
Accepted: 4 November 2024
First Online: 26 November 2024
Change Date: 10 September 2025
Change Type: Update
Change Details: The original version of this paper has been updated. In the Acknowledgements section of the article, the family name Mahbuba was mistakenly listed as Mahuba.
Declarations
:
: NNM has served as a consultant for receiving and received grants/other payments from AbbVie, Celgene, Janssen Pharmaceuticals, Novartis, AMGEN, Astra Zeneca, Abcentra, Tourmaline, Bristol Meyers Squibb, Sun Pharmaceuticals and Celgene. EdG is an employee of Tourmaline Bio, Inc. MDS is supported by institutional grants from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, New Amsterdam, and Cleerly. MDS has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. MDS has also served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline.
: No human or animal subjects by the authors were used in this study.